Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study

Authors:

Abstract
No abstract available
Funding Information
  • Roche

This publication has 34 references indexed in Scilit: